API reference
Revefenacin
- CAS number
- 864750-70-9
- Molecular formula
- C35H43N5O4
- Molecular weight
- 597.7 g/mol
About this molecule
Revefenacin is a novel biphenyl carbamate tertiary amine agent that belongs to the family of the long-acting muscarinic antagonists (LAMA). The labile primary amide in the structure produces a "soft-drug" site that allows rapid systemic clearance and minimizing of the systemically mediated adverse reactions. The LAMA group falls into a parent category known as long-acting inhaled bronchodilators and this type of agents are recommended as a maintenance therapy for chronic obstructive pulmonary disease (COPD). From the LAMA group, revefenacin is the first once-daily nebulized LAMA treatment. It was developed by Theravance Biopharma and FDA approved on November 9, 2018.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
- InChIKey
- FYDWDCIFZSGNBU-UHFFFAOYSA-N
- SMILES
- CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N
- Other CAS numbers recorded
- 1211931-83-7
- PubChem CID
- 11753673
Also known as
Revefenacin · Yupelri · revefenacina · revefenacine · revefenacinum · R03BB08 · Yupelri (TN) · Revefenacin (Standard)
Related entries in the range
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.